Literature DB >> 35612680

Ab initio study of superoxide dismutase (SOD) and catalase activity of EUK-134.

Mun-Hyok Ri1, Un-Son Ri2, Hyon-U Han3, Son-Yong Ko3, Nam-Hyok Kim2, Kyong-Song Jang3, Kyong-Il Kim3, Yun-Sop Sin2.   

Abstract

Dismutation reaction of superoxide radical catalyzed by EUK-134 has lower activation energy than non-catalytic reaction, and therefore, EUK-134 catalyzes dismutation reaction of superoxide radical. For non-catalytic dismutation reaction of hydrogen peroxide, there are three possible reaction paths, among which MEP3 has the lowest activation energy, and therefore, is thought to be the most probable reaction path. Dismutation reaction of hydrogen peroxide catalyzed by EUK-134 occurs in two successive steps and has lower energy barrier than non-catalytic dismutation reaction, and therefore, EUK-134 is thought to catalyze the dismutation reaction of hydrogen peroxide. HOMO (highest occupied molecular orbital) and LUMO (lowest unoccupied molecular orbital) and ESP-fitted charge analysis of EUK-134 indicate that Mn atom plays an electron acceptor and donor for dismutation reactions of superoxide radical and hydrogen peroxide catalyzed by EUK-134, respectively.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Ab initio; Catalase; EUK-134; NEB; SOD

Mesh:

Substances:

Year:  2022        PMID: 35612680     DOI: 10.1007/s00894-022-05129-4

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  3 in total

Review 1.  Roles of nitric oxide and superoxide in inflammation.

Authors:  Daniela Salvemini; Harry Ischiropoulos; Salvatore Cuzzocrea
Journal:  Methods Mol Biol       Date:  2003

2.  Catalase-overexpressing transgenic mouse heart is resistant to ischemia-reperfusion injury.

Authors:  G Li; Y Chen; J T Saari; Y J Kang
Journal:  Am J Physiol       Date:  1997-09

Review 3.  Biology of disease: free radicals and tissue injury.

Authors:  B A Freeman; J D Crapo
Journal:  Lab Invest       Date:  1982-11       Impact factor: 5.662

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.